Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03921359 · ClinicalTrials.gov registry record · NA

SMARTfit Training for Parkinson's Disease

A NA study, sponsored by University of Southern California.

Terminated
Registry status
NA
Development phase
9
Enrollment target

NCT03921359: Clinical Trial NA study, sponsored by University of Southern California.

NCT03921359 is a NA study that was terminated before completion, run by University of Southern California. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03921359, a NA study, was terminated before completion, sponsored by University of Southern California.

TERMINATED
Registry status
NA
Development phase
9 participants
Enrollment target

Study Summary

This pilot study aims to investigate the effects of 8-week SMARTfit training versus conventional physical training on motor function, cognition and brain functional connectivity in individuals with PD. The investigators hypothesize that clinical and physical performance will improve after SMARTfit training more than after conventional physical training.

Primary Outcome

The mPPT is a 9-item test that assesses multiple dimensions of physical function (basic and complex activities of daily living) with different levels of difficulty. Participants will be asked to complete functional tasks (i.e. writing a sentence, simulated eating, lift a book and put it on a shelf, turning 360 degrees, 50-foot walking test, stair climbing etc.). Total score ranges from 0 to 36, with a higher score indicating better physical function.

Interventions

  • BEHAVIORAL SMARTfit training
  • BEHAVIORAL Conventional physical training

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2018-05-19
Est. Completion 2020-03-16
Phase NA
University of Southern California

617 total trials

Why NCT03921359 stopped before completion

NCT03921359 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which SMARTfit training is the first listed.

NCT03921359 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03921359 about?

NCT03921359 is a clinical study titled "SMARTfit Training for Parkinson's Disease". This pilot study aims to investigate the effects of 8-week SMARTfit training versus conventional physical training on motor function, cognition and brain functional connectivity in individuals with PD. The investigators hypothesize that clinical and physical performance will improve after SMARTfit t...

What is the current status of trial NCT03921359?

This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2018-05-19. Estimated completion is 2020-03-16.

What interventions are being tested in trial NCT03921359?

The interventions under investigation include: SMARTfit training (BEHAVIORAL), Conventional physical training (BEHAVIORAL).

Who is sponsoring clinical trial NCT03921359?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03921359's enrollment target sits among peer trials

9 1975th of 2000 higher than 25 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03921359, the US trial registry maintained by the National Library of Medicine. NCT03921359 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.